BioSpace News Archive

Pharm Country

OKYO Pharma Today Announces Director Acquires Shares

OKYO Pharma Limited announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 12,500 of the Company’s ADSs on NASDAQ at a price of US$1.32 per ADS at a price of £0.0165 each).

March 29, 2023
·
2 min read
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment

Pharmaron Beijing Co., Limited announced that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s Life Sciences Innovation Manufacturing Fund to expand their viral vector and DNA manufacturing facilities for more than 8,000 sqM.

March 29, 2023
·
3 min read
Biotech Bay

Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas

Mainz Biomed NV announced results of an independent feasibility study conducted in collaboration with members of the Early Detection Research Network to evaluate the Company’s portfolio of five novel gene expression biomarkers acquired from Université de Sherbrooke in January, 2022.

March 29, 2023
·
10 min read
Business

Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

Synlogic, Inc., the leading company advancing therapeutics based on synthetic biology, reported financial results for the fourth quarter and full year ending December 31, 2022 and provided a business update.

March 29, 2023
·
8 min read
Genetown

Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference

Entrada Therapeutics, Inc. today announced that Dipal Doshi, President and Chief Executive Officer, will participate in a virtual fireside chat during the Guggenheim Genomic Medicines and Rare Disease Conference on Tuesday, April 4, 2023 at 9:00 a.m. Eastern Time.

March 29, 2023
·
1 min read
Business

Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer

Lavie Bio Ltd. today is pleased to announce the appointment of Mr. Amit Noam as Chief Executive Officer (“CEO”) of Lavie Bio, effective as of April 16, 2023.

March 29, 2023
·
5 min read
FDA

EpicentRx Receives Fast Track Designation from the U.S. FDA for Lead Asset, RRx-001, to Prevent/Attenuate Chemotherapy and Radiation Treatment Induced Severe Oral Mucositis

EpicentRx, Inc. (“EpicentRx”), announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RRx-001, a direct NLRP3 inhibitor and Nrf2.

March 29, 2023
·
2 min read
Business

Nevro to Report First Quarter 2023 Financial Results

Nevro Corp. today announced that the company will report its financial results for the first quarter ended March 31, 2023 after the market closes on April 26, 2023.

March 29, 2023
·
2 min read
Silence Therapeutics to Present at Guggenheim’s Genomic Medicines and Rare Disease Days

Silence Therapeutics plc today announced that Company management will participate in a virtual fireside chat at Guggenheim’s Genomic Medicines and Rare Disease Days on Tuesday April 4th at 2:10 p.m. ET.

March 29, 2023
·
1 min read
Business

Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer

Lucy Therapeutics, Inc. today announced the appointment of Christopher J. Winrow, Ph.D., a neuroscience and translational medicine expert, as Chief Scientific Officer.

March 29, 2023
·
4 min read